Zurich Cantonal Bank
IONS icon

Zurich Cantonal Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Zurich Cantonal Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,921
Closed -$3.87M – 3020
2025
Q4 		$3.87M Buy
+48,921
New +$3.68M 0.01% 696

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's IONS Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 60,239 shares worth $4.52M. The stake represents 0.01% of the portfolio and ranks #688 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IONS as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in IONS in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.86M in Q2 2014. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Zurich Cantonal Bank held 60,239 shares of Ionis Pharmaceuticals worth $4.52M as of Q1 2026.
  • Ionis Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #688 holding.
  • Zurich Cantonal Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Zurich Cantonal Bank's Ionis Pharmaceuticals position peaked at $4.86M in Q2 2014.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.